180 related articles for article (PubMed ID: 16467136)
1. Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.
Zollinger M; Waldmeier F; Hartmann S; Zenke G; Zimmerlin AG; Glaenzel U; Baldeck JP; Schweitzer A; Berthier S; Moenius T; Grassberger MA
Drug Metab Dispos; 2006 May; 34(5):765-74. PubMed ID: 16467136
[TBL] [Abstract][Full Text] [Related]
2. Disposition of lasofoxifene, a next-generation selective estrogen receptor modulator, in healthy male subjects.
Prakash C; Johnson KA; Gardner MJ
Drug Metab Dispos; 2008 Jul; 36(7):1218-26. PubMed ID: 18372400
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
Waldmeier F; Glaenzel U; Wirz B; Oberer L; Schmid D; Seiberling M; Valencia J; Riviere GJ; End P; Vaidyanathan S
Drug Metab Dispos; 2007 Aug; 35(8):1418-28. PubMed ID: 17510248
[TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.
Gschwind HP; Waldmeier F; Zollinger M; Schweitzer A; Grassberger M
Eur J Pharm Sci; 2008 Jan; 33(1):9-19. PubMed ID: 17996430
[TBL] [Abstract][Full Text] [Related]
5. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
6. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
8. Disposition of [1'-(14)C]stavudine after oral administration to humans.
Zhou L; Kaul S; Liu-Kreyche P; Tran SB; Espina RR; Warrack BM; Roongta VA; Iyer RA
Drug Metab Dispos; 2010 Apr; 38(4):655-66. PubMed ID: 20053818
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of imatinib mesylate in healthy volunteers.
Gschwind HP; Pfaar U; Waldmeier F; Zollinger M; Sayer C; Zbinden P; Hayes M; Pokorny R; Seiberling M; Ben-Am M; Peng B; Gross G
Drug Metab Dispos; 2005 Oct; 33(10):1503-12. PubMed ID: 16006570
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans.
Yi P; Hadden C; Kulanthaivel P; Calvert N; Annes W; Brown T; Barbuch RJ; Chaudhary A; Ayan-Oshodi MA; Ring BJ
Drug Metab Dispos; 2010 Apr; 38(4):554-65. PubMed ID: 20075192
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.
Mountfield RJ; Kiehr B; John BA
Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of the metabotropic glutamate receptor 5 antagonist (mGluR5) mavoglurant (AFQ056) in healthy subjects.
Walles M; Wolf T; Jin Y; Ritzau M; Leuthold LA; Krauser J; Gschwind HP; Carcache D; Kittelmann M; Ocwieja M; Ufer M; Woessner R; Chakraborty A; Swart P
Drug Metab Dispos; 2013 Sep; 41(9):1626-41. PubMed ID: 23775850
[TBL] [Abstract][Full Text] [Related]
14. Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans.
Karanam B; Madeira M; Bradley S; Wenning L; Desai R; Soli E; Schenk D; Jones A; Dean B; Doss G; Garrett G; Crumley T; Nirula A; Lai E
Drug Metab Dispos; 2007 Jul; 35(7):1196-202. PubMed ID: 17431030
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro.
Gschwind HP; Glaenzel U; Waldmeier F; Wirz B; Sabia HD; Picard F; Weiss HM; Choi L; Swart PJ; Vasudevan A; Azria M
Eur J Pharm Sci; 2012 Aug; 47(1):44-55. PubMed ID: 22579664
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of cyclosporin G in humans.
Mangold JB; Schran HF; Tse FL
Drug Metab Dispos; 1994; 22(6):873-9. PubMed ID: 7895604
[TBL] [Abstract][Full Text] [Related]
19. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.
Dai Y; Hebert MF; Isoherranen N; Davis CL; Marsh C; Shen DD; Thummel KE
Drug Metab Dispos; 2006 May; 34(5):836-47. PubMed ID: 16501005
[TBL] [Abstract][Full Text] [Related]
20. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
